These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 12547017)

  • 1. Selective retinoids and rexinoids in cancer therapy and chemoprevention.
    Zusi FC; Lorenzi MV; Vivat-Hannah V
    Drug Discov Today; 2002 Dec; 7(23):1165-74. PubMed ID: 12547017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retinoids and rexinoids in cancer prevention: from laboratory to clinic.
    Uray IP; Dmitrovsky E; Brown PH
    Semin Oncol; 2016 Feb; 43(1):49-64. PubMed ID: 26970124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renaissance of the biologically active vitamin A derivatives: established and novel directed therapies for cancer and chemoprevention.
    Brtko J; Thalhamer J
    Curr Pharm Des; 2003; 9(25):2067-77. PubMed ID: 14529416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retinoids, rexinoids and their cognate nuclear receptors: character and their role in chemoprevention of selected malignant diseases.
    Brtko J
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2007 Dec; 151(2):187-94. PubMed ID: 18345250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retinoids as chemopreventive agents.
    Ralhan R; Kaur J
    J Biol Regul Homeost Agents; 2003; 17(1):66-91. PubMed ID: 12757022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthetic retinoids and their nuclear receptors.
    Dawson MI
    Curr Med Chem Anticancer Agents; 2004 May; 4(3):199-230. PubMed ID: 15134501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of retinoid X receptor-selective ligands on proliferation of prostate cancer cells.
    de Vos S; Dawson MI; Holden S; Le T; Wang A; Cho SK; Chen DL; Koeffler HP
    Prostate; 1997 Jul; 32(2):115-21. PubMed ID: 9215399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retinoids in cancer therapy and chemoprevention: promise meets resistance.
    Freemantle SJ; Spinella MJ; Dmitrovsky E
    Oncogene; 2003 Oct; 22(47):7305-15. PubMed ID: 14576840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of mammary tumorigenesis in transgenic mice by the RXR-selective retinoid, LGD1069.
    Wu K; Kim HT; Rodriquez JL; Hilsenbeck SG; Mohsin SK; Xu XC; Lamph WW; Kuhn JG; Green JE; Brown PH
    Cancer Epidemiol Biomarkers Prev; 2002 May; 11(5):467-74. PubMed ID: 12010861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential regulation of human ectocervical epithelial cell line proliferation and differentiation by retinoid X receptor- and retinoic acid receptor-specific retinoids.
    Agarwal C; Chandraratna RA; Teng M; Nagpal S; Rorke EA; Eckert RL
    Cell Growth Differ; 1996 Apr; 7(4):521-30. PubMed ID: 9052993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effects of synthetic nuclear retinoid receptor-selective retinoids on the growth of human non-small cell lung carcinoma cells.
    Sun SY; Yue P; Dawson MI; Shroot B; Michel S; Lamph WW; Heyman RA; Teng M; Chandraratna RA; Shudo K; Hong WK; Lotan R
    Cancer Res; 1997 Nov; 57(21):4931-9. PubMed ID: 9354460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conformationally defined 6-s-trans-retinoic acid analogs. 3. Structure-activity relationships for nuclear receptor binding, transcriptional activity, and cancer chemopreventive activity.
    Muccio DD; Brouillette WJ; Alam M; Vaezi MF; Sani BP; Venepally P; Reddy L; Li E; Norris AW; Simpson-Herren L; Hill DL
    J Med Chem; 1996 Sep; 39(19):3625-35. PubMed ID: 8809153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retinoids and TRAIL: two cooperating actors to fight against cancer.
    Altucci L; Gronemeyer H
    Vitam Horm; 2004; 67():319-45. PubMed ID: 15110184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic advances in cutaneous T-cell lymphoma (CTCL): from retinoids to rexinoids.
    Stadler R; Kremer A
    Semin Oncol; 2006 Feb; 33(1 Suppl 3):S7-10. PubMed ID: 16516669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Traffic lights for retinoids in oncology: molecular markers of retinoid resistance and sensitivity and their use in the management of cancer differentiation therapy.
    Dobrotkova V; Chlapek P; Mazanek P; Sterba J; Veselska R
    BMC Cancer; 2018 Nov; 18(1):1059. PubMed ID: 30384831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retinoids in chemoprevention of cancer.
    Verma AK
    J Biol Regul Homeost Agents; 2003; 17(1):92-7. PubMed ID: 12757023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclin proteolysis as a retinoid cancer prevention mechanism.
    Dragnev KH; Freemantle SJ; Spinella MJ; Dmitrovsky E
    Ann N Y Acad Sci; 2001 Dec; 952():13-22. PubMed ID: 11795432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent developments in receptor-selective retinoids.
    Nagpal S; Chandraratna RA
    Curr Pharm Des; 2000 Jun; 6(9):919-31. PubMed ID: 10828316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic applications for ligands of retinoid receptors.
    Thacher SM; Vasudevan J; Chandraratna RA
    Curr Pharm Des; 2000 Jan; 6(1):25-58. PubMed ID: 10637371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent advances in the use of vitamin A (retinoids) in the prevention and treatment of cancer.
    Niles RM
    Nutrition; 2000; 16(11-12):1084-9. PubMed ID: 11118831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.